Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 1, q subcomponent binding protein (C1QBP), also known as p32 or gC1qR, is a highly acidic, multifunctional protein primarily localized within the mitochondrial matrix, though it also resides in the nucleus, cytosol, and on the cell surface. It is essential for the maintenance of mitochondrial oxidative phosphorylation (OXPHOS) by regulating the translation of mitochondrial-encoded polypeptides. In many cancers, C1QBP is significantly overexpressed and translocated to the plasma membrane, where it serves as a receptor for ligands like C1q, hyaluronan, and various viral proteins, promoting tumor progression, angiogenesis, and metabolic reprogramming. Because of its preferential expression on the surface of tumor cells and tumor-associated macrophages, it is a target for diagnostic imaging and targeted therapy using peptides like LyP-1 and specific monoclonal antibodies. Therapeutic modulation of C1QBP aims to disrupt mitochondrial energy production or trigger apoptosis in malignant cells while sparing normal tissues. However, its critical role in mitochondrial function poses challenges regarding potential toxicity in healthy, high-energy-demanding organs (PubMed: ).
Inhibition of mitochondrial oxidative phosphorylation, blockade of cell surface receptor-ligand interactions, and induction of tumor-specific apoptosis.
2 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component 1, q subcomponent binding protein (C1QBP) (C1QBP).